Bharat Biotech

Showing of 21 - 40 from 28 results
Bharat Biotech - Total results - 28
Scientists caution govt over plans to fast-track 'Made in India' vaccine, COVAXIN
India

Scientists caution govt over plans to fast-track 'Made in India' vaccine, COVAXIN

A virologist said that a vaccine normally takes at least 12-18 months to pass all necessary clinical trial phases while the company developing it has just over a month to wrap up everything

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost
India

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost

Hyderabad-based Bharat Biotech, one of seven Indian companies involved in the indigenous production of a vaccine for the novel coronavirus, received the green signal from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of 'Covaxin' last week.

COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
India

COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July

The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.

Coronavirus Updates: Centre tells states to enable all doctors, including private practitioners, to prescribe COVID-19 tests
India

Coronavirus Updates: Centre tells states to enable all doctors, including private practitioners, to prescribe COVID-19 tests

Coronavirus LIVE Updates: Union health secretary Preeti Sudan and ICMR director general Balram Bhargava on Wednesday wrote to state governments and Union territories to increase testing.

India's first COVID-19 vaccine, COVAXIN, by Bharat Biotech gets DCGI nod for human clinical trials
India

India's first COVID-19 vaccine, COVAXIN, by Bharat Biotech gets DCGI nod for human clinical trials

The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month.

Potential COVID-19 vaccines: From a self-limiting virus to a self-assembling vaccine, scientists are pulling out all the stops
Health

Potential COVID-19 vaccines: From a self-limiting virus to a self-assembling vaccine, scientists are pulling out all the stops

There is currently no authorized treatment for the infection, though various governments have green-lighted emergency treatments with little evidence.

PM launches first indigenously developed Rotavirus vaccine
Life

PM launches first indigenously developed Rotavirus vaccine

Billed as one of the first novel vaccines to be developed completely in the developing world, it is expected to help in significant reduction in infant deaths due to Rotavirus diarrhoea in India and other parts of the world.

Anti-diarrhoea vaccine: Why social innovation is the way ahead for Indian healthcare
India

Anti-diarrhoea vaccine: Why social innovation is the way ahead for Indian healthcare

The old model - of pharma companies deciding what and when to develop new drugs – is crumbling.